Merck KGaA/Auxogyn’s Eeva System Gets FDA Clearance – Analyst Blog
Merck KGaA ‘s ( MKGAF ) biopharma division, Merck Serono, announced that the FDA has granted clearance to Merck KGaA …read more
Investing and Market Analysis
MetLife Resumes Stock Buyback, Shares Gain – Analyst Blog
For the first time since 2008, the board of global multi line insurer, MetLife Inc. ( MET ) announced its …read more
NPS Pharma’s Natpara Likely to be Reviewed in September – Analyst Blog
NPS Pharmaceuticals ( NPSP ) announced that the tentative review date of the biologics license application (BLA) for Natpara, by …read more
Chubb Corp. Balances Risk, Reward – Analyst Blog
On June 10, we issued an updated research report on property and casualty insurer The Chubb Corp. ( CB ). …read more
ConocoPhillips Scales a 52-Week High – Analyst Blog
Shares of ConocoPhillips ( COP ) touched a 52 week high of $81.66 on Jun 10, 2014. The stock closed …read more
SodaStream Introduces New Sparkling Drink Flavors – Analyst Blog
SodaStream International, Ltd. ( SODA ) has entered into a strategic alliance with Cooking Light, a leading epicurean brand, to …read more
Halliburton Hits 52-week High at $67.35 – Analyst Blog
Shares of Halliburton Company ( HAL ) hit a 52 week high of $67.35 on Jun 10, 2014. In fact, …read more
Is Tiffany Gaining Sheen on Higher Sales? – Analyst Blog
After missing the Zacks Consensus Estimate in the final quarter of fiscal 2013, Tiffany & Company ( TIF ) is …read more
Bonds? Or Stocks?
Here’s what today’s article has to say about stocks versus bonds, “The stock market’s daily drift to new highs and the low yields in the… Read More »Bonds? Or Stocks?
Masimo Gains on Positive PVI & SpHb Study Data – Analyst Blog
Masimo Corporation ( MASI ) recently presented results from four new clinical studies evaluating its non invasive patient monitoring technologies. …read more